UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, DC 20549
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934
Date of Report (Date of earliest event reported): August 8, 2014 (August 7, 2014)
Medical Action Industries Inc.
(Exact name of registrant as specified in its charter)
|
Delaware
|
000-13251
|
11-2421849
|
|
(State or other jurisdiction
|
(Commission
|
(IRS Employer
|
|
of incorporation)
|
File Number)
|
Identification No.)
|
|
500 Expressway Drive South
|
|
|
Brentwood, New York
|
11717
|
|
(Address of principal executive offices)
|
(Zip Code)
|
Registrant’s telephone number, including area code:
(631) 231-4600
Not applicable
(Former name or former address, if changed since last report)
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligations of the registrant under any of the following provisions (see General Instruction A.2. below):
o Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
o Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
o Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
o Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
Item 5.07 Submission of Matters to a Vote of Security Holders
Medical Action Industries Inc. (the “Company”) held its Annual Meeting of Stockholders on August 7, 2014. Set forth below are the final voting results for each of the three proposals submitted to a stockholder vote.
Proposal No. 1 — Election of Class III Directors. The election of the Class III director nominees was approved as follows:
|
Nominee
|
For
|
Withheld
|
Broker Non-Votes
|
|||||
|
William W. Burke
|
10,625,998.72
|
431,055
|
4,028,568
|
|||||
|
Kenneth W. Davidson
|
10,694,587.02
|
362,466.70
|
4,028,568
|
|||||
Proposal No. 2 — Ratification of the Selection of KPMG LLP. The ratification of the selection of KPMG LLP as the Company’s independent registered public accounting firm for the fiscal year ending March 31, 2015 was approved as follows:
|
For
|
Against
|
Abstain
|
||
|
15,019,342.09
|
29,411
|
36,868.63
|
Proposal No. 3 — Approval, on an Advisory Basis, of the Compensation of the Company’s Named Executive Officers. The compensation of the Company’s named executive officers was approved on an advisory basis as follows:
|
For
|
Against
|
Abstain
|
Broker Non-Votes
|
|||
|
8,884,116.56
|
1,478,861.16
|
694,076
|
4,028,568
|
SIGNATURE
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.
|
MEDICAL ACTION INDUSTRIES INC.
|
|||
| By: |
/s/ Brian Baker
|
||
|
Brian Baker
|
|||
|
Chief Financial Officer
|
|||
Dated: August 8, 2014